Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs. Duramorph for post-cesarean analgesia
NCT03638011Phase 4Terminated
- Sponsor
- Maimonides Medical Center
- Start
- Sep 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in postoperative pain comparing Standard of Care with Bilateral TAP Block (2 arms). Primary endpoints: Pain Assessed by Visual Analog Scale at 48 Hours and Pain Assessed by Visual Analog Scale at 72 Hours. Started Sep 2018; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03638011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03638011.